Who has invested in SalubrisBio?

Shenzhen Salubris Pharmaceuticals Co., Ltd. are named among the investors backing SalubrisBio.

SalubrisBio Funding: $67M Raised, Series A (2024)

SalubrisBio funding overview

SalubrisBio is based in Gaithersburg. SalubrisBio has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for SalubrisBio runs through 2024; nothing later has been disclosed. Investors on record include Shenzhen Salubris Pharmaceuticals Co., Ltd..

SalubrisBio at a glance

Total raised: $67M
Latest round: Series A
Latest round date: January 2024
Headquarters: Gaithersburg
Notable investors: Shenzhen Salubris Pharmaceuticals Co., Ltd.

Frequently asked about SalubrisBio funding

How much has SalubrisBio raised?: SalubrisBio has raised $67M in total disclosed funding across the rounds on record.
Who has invested in SalubrisBio?: Shenzhen Salubris Pharmaceuticals Co., Ltd. are named among the investors backing SalubrisBio.
What was the latest SalubrisBio funding round?: The most recent disclosed round is a Series A, announced in January 2024.
Where is SalubrisBio based?: SalubrisBio is based in Gaithersburg.
When did SalubrisBio last raise?: The last disclosed SalubrisBio round closed in January 2024 at Series A.

We update the SalubrisBio record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Gaithersburg and their backers are listed below.

SalubrisBio Funding: $67M Raised, Series A (2024)

SalubrisBio funding overview

SalubrisBio at a glance

Frequently asked about SalubrisBio funding

Companies related to SalubrisBio (36)

Browse related funding lists (3)